BRPI0417995A - formas de dosagem personalizadas para o consumidor - Google Patents

formas de dosagem personalizadas para o consumidor

Info

Publication number
BRPI0417995A
BRPI0417995A BRPI0417995-1A BRPI0417995A BRPI0417995A BR PI0417995 A BRPI0417995 A BR PI0417995A BR PI0417995 A BRPI0417995 A BR PI0417995A BR PI0417995 A BRPI0417995 A BR PI0417995A
Authority
BR
Brazil
Prior art keywords
dosage forms
consumer
custom
custom dosage
sweetness
Prior art date
Application number
BRPI0417995-1A
Other languages
English (en)
Inventor
Marni L Allen
Frank J Bunick
Stephan G Wiet
Stephen J Saldutti
Paul D Bisio
Jeffrey Morrill
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Publication of BRPI0417995A publication Critical patent/BRPI0417995A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00—ICT specially adapted for the handling or processing of medical references
    • G16H70/40—ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Primary Health Care (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"FORMAS DE DOSAGEM PERSONALIZADAS PARA O CONSUMIDOR". A presente invenção refere-se a formas de dosagem que podem ser personalizadas. O sabor, cor, adoçamento, ou a textura das formas de dosagem podem ser personalizados diretamente pelo consumidor.
BRPI0417995-1A 2003-12-22 2004-12-16 formas de dosagem personalizadas para o consumidor BRPI0417995A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/743,126 US20050136105A1 (en) 2003-12-22 2003-12-22 Consumer customized dosage forms
PCT/US2004/042398 WO2005063208A1 (en) 2003-12-22 2004-12-16 Consumer customized dosage forms

Publications (1)

Publication Number Publication Date
BRPI0417995A true BRPI0417995A (pt) 2007-04-27

Family

ID=34678574

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0417995-1A BRPI0417995A (pt) 2003-12-22 2004-12-16 formas de dosagem personalizadas para o consumidor

Country Status (11)

Country Link
US (1) US20050136105A1 (pt)
EP (1) EP1706096B1 (pt)
KR (1) KR20060128926A (pt)
CN (1) CN1897916A (pt)
AT (1) ATE444733T1 (pt)
BR (1) BRPI0417995A (pt)
CA (1) CA2549018C (pt)
DE (1) DE602004023539D1 (pt)
MX (1) MXPA06007212A (pt)
NO (1) NO20063418L (pt)
WO (1) WO2005063208A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7371405B2 (en) 2003-12-22 2008-05-13 Mcneil-Ppc, Inc. Consumer customized dosage forms
EP1836665B1 (en) * 2004-11-19 2013-01-16 GlaxoSmithKline LLC Method for customized dispensing of variable dose drug combination products for individualizing of therapies
US20070082061A1 (en) * 2005-10-07 2007-04-12 Nelson Ayala Reduction of saltiness with sweeteners
US8207553B2 (en) * 2008-03-25 2012-06-26 Bridge Semiconductor Corporation Semiconductor chip assembly with base heat spreader and cavity in base
US20220249397A1 (en) * 2021-02-07 2022-08-11 Function Better Inc. Automated Dosing Protocol for Use of Cannabinoids or Other Psychoactive Substances
US12605388B2 (en) 2024-09-25 2026-04-21 Azurity Pharmaceuticals Ireland Limited Lamotrigine salts, co-crystals, and compositions

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4071614A (en) * 1975-06-03 1978-01-31 Colgate Palmolive Company Dentifrice containing encapsulated flavoring
EP0025269B1 (en) * 1979-08-23 1985-11-13 Beecham Group Plc Anti-diarrhoea veterinary composition
US5628799A (en) * 1991-09-26 1997-05-13 Clairol Incorporated Hair dying methods and kits which contain a dopa species, reactive direct dye, and a ferricyanide oxidant
US5620707A (en) * 1993-06-29 1997-04-15 The Procter & Gamble Company Beadlets for customization of flavor and sweetener in a beverage
US5695930A (en) * 1994-11-10 1997-12-09 Weinstein; David E. HIV test kit method for detecting anti-HIV-I antibodies in saliva
ATE226814T1 (de) * 1995-05-23 2002-11-15 Smithkline Beecham Plc Pharmazeutische zusammensetzung hergestellt durch zugabe eines geschmackstoff an einer wirkstoff
US6265427B1 (en) * 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
ZA200003120B (en) * 1999-06-30 2001-01-02 Givaudan Roure Int Encapsulation of active ingredients.
US6570013B2 (en) * 2000-02-16 2003-05-27 Pfizer Inc Salts of zopolrestat
US6380232B1 (en) * 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
SK8552003A3 (en) * 2001-01-25 2004-06-08 Bristol Myers Squibb Co Parenteral formulation containing epothilone analogs
US7371405B2 (en) * 2003-12-22 2008-05-13 Mcneil-Ppc, Inc. Consumer customized dosage forms

Also Published As

Publication number Publication date
MXPA06007212A (es) 2007-01-19
DE602004023539D1 (de) 2009-11-19
WO2005063208A1 (en) 2005-07-14
CA2549018C (en) 2012-04-03
EP1706096A1 (en) 2006-10-04
EP1706096B1 (en) 2009-10-07
US20050136105A1 (en) 2005-06-23
NO20063418L (no) 2006-09-21
CN1897916A (zh) 2007-01-17
CA2549018A1 (en) 2005-07-14
KR20060128926A (ko) 2006-12-14
ATE444733T1 (de) 2009-10-15
HK1093910A1 (en) 2007-03-16

Similar Documents

Publication Publication Date Title
MXPA05009112A (es) Mezclas herbicidas de accion sinergica.
EG25344A (en) Substituted morpholine and thiomorpholine derivatives.
IL180534A0 (en) W.c. dispenser with perfuming chamber
BRPI0417986A (pt) formas de dosagem customizadas pelo consumidor
ITRM20010044A0 (it) Integratore alimentare ad effetto dimagrante.
NO20063418L (no) Konsumenttilpassede dosringsformer
FR2855029B1 (fr) Cache-pot.
BRPI0402574B1 (pt) combinada agrìcola.
ES1056134Y (es) Hebilla.
ITMO20030015A1 (it) Preparazione alimentare.
ITRM20030530A1 (it) Conformatrice congelatrice per pasta precotta.
ITPS20030037A1 (it) Preparato complemento alimentare.
ES1054898Y (es) Video-postal.
ITRM20030077V0 (it) Caffettiera.
ES1055844Y (es) Taco abrasivo.
ES1052046Y (es) Dispensador de productos rayados, en polvo o en grano.
ITRM20040022A1 (it) Cuoci-servi alimenti.
GB0307972D0 (en) E.b.o.e.s.s
ITRM20030537A1 (it) Integratore radio-filo.
ITMI20022792A1 (it) Integratore alimentare per flebopatici.
ES1058159Y (es) Taco.
ITRM20030122A0 (it) Piatto doccia.
ES1056022Y (es) Refrigerador.
ITFE20030010A1 (it) Atomizzatore per barbatelle.
ES1055839Y (es) Disposicion de asiento.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 12A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 47/46 (2006.01), A61K 47/26 (2006.01), G06Q 5